Corrigendum to ‘Current Use and Trends in Hematopoietic Cell Transplantation in the United States’ [Transplantation and Cellular Therapy 26/8 (2020) e177-e182, (S1083879120302251), (10.1016/j.bbmt.2020.04.013)]

Anita D'Souza; Caitrin Fretham; Stephanie J. Lee; Mukta Arora; Janet Brunner; Saurabh Chhabra; Steven Devine; Mary Eapen; Mehdi Hamadani; Parameswaran Hari; Marcelo C. Pasquini; Waleska Perez; Rachel A. Phelan; Marcie L. Riches; J. Douglas Rizzo; Wael Saber; Bronwen E. Shaw; Stephen R. Spellman; Patricia Steinert; Daniel J. Weisdorf; Mary M. Horowitz

doi:10.1016/j.jtct.2021.02.006

Corrigendum to ‘Current Use and Trends in Hematopoietic Cell Transplantation in the United States’ [Transplantation and Cellular Therapy 26/8 (2020) e177-e182, (S1083879120302251), (10.1016/j.bbmt.2020.04.013)]

Anita D'Souza, Caitrin Fretham, Stephanie J. Lee, Mukta Arora, Janet Brunner, Saurabh Chhabra, Steven Devine, Mary Eapen, Mehdi Hamadani, Parameswaran Hari, Marcelo C. Pasquini, Waleska Perez, Rachel A. Phelan, Marcie L. Riches, J. Douglas Rizzo, Wael Saber, Bronwen E. Shaw, Stephen R. Spellman, Patricia Steinert, Daniel J. WeisdorfMary M. Horowitz

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Abstract

The authors regret an error in the original paper wherein the number of patients with Diffuse Large B Cell Lymphoma (DLBCL) undergoing autologous hematopoietic cell transplantation in the U.S. in 2018 was incorrectly reported. Prior to 2018, the majority of DLBCL were collected under the category ‘NHL diffuse, large B-cell. To align data reporting with 2016 World Health Organization classification of lymphoid neoplasms, in 2018, the CIBMTR forms added new categories (including, DLBCL – germinal center B-cell type, DLBCL – activated B-cell type, and NHL with c-myc and bcl-2 and/or bcl6 rearrangements). We erroneously did not include these newly added subsets of DLBCL, resulting in the appearance of fewer patients undergoing autologous hematopoietic cell transplantation for DLBCL in 2018. Upon identification of this error, we have created an updated Figure 3. The authors would like to apologise for any inconvenience caused.

Original language	English (US)
Pages (from-to)	715-716
Number of pages	2
Journal	Transplantation and Cellular Therapy
Volume	28
Issue number	10
DOIs	https://doi.org/10.1016/j.jtct.2021.02.006
State	Published - Oct 2022

Bibliographical note

Publisher Copyright:
© 2021 The American Society for Transplantation and Cellular Therapy

PubMed: MeSH publication types

Published Erratum

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1016/j.jtct.2021.02.006

OpenUrl availability

Full text

Fingerprint

Dive into the research topics of 'Corrigendum to ‘Current Use and Trends in Hematopoietic Cell Transplantation in the United States’ [Transplantation and Cellular Therapy 26/8 (2020) e177-e182, (S1083879120302251), (10.1016/j.bbmt.2020.04.013)]'. Together they form a unique fingerprint.

Cite this

D'Souza, A., Fretham, C., Lee, S. J., Arora, M., Brunner, J., Chhabra, S., Devine, S., Eapen, M., Hamadani, M., Hari, P., Pasquini, M. C., Perez, W., Phelan, R. A., Riches, M. L., Rizzo, J. D., Saber, W., Shaw, B. E., Spellman, S. R., Steinert, P., ... Horowitz, M. M. (2022). Corrigendum to ‘Current Use and Trends in Hematopoietic Cell Transplantation in the United States’ [Transplantation and Cellular Therapy 26/8 (2020) e177-e182, (S1083879120302251), (10.1016/j.bbmt.2020.04.013)]. Transplantation and Cellular Therapy, 28(10), 715-716. https://doi.org/10.1016/j.jtct.2021.02.006

Corrigendum to ‘Current Use and Trends in Hematopoietic Cell Transplantation in the United States’ [Transplantation and Cellular Therapy 26/8 (2020) e177-e182, (S1083879120302251), (10.1016/j.bbmt.2020.04.013)]. / D'Souza, Anita; Fretham, Caitrin; Lee, Stephanie J. et al.
In: Transplantation and Cellular Therapy, Vol. 28, No. 10, 10.2022, p. 715-716.

Research output: Contribution to journal › Comment/debate › peer-review

D'Souza, A, Fretham, C, Lee, SJ, Arora, M, Brunner, J, Chhabra, S, Devine, S, Eapen, M, Hamadani, M, Hari, P, Pasquini, MC, Perez, W, Phelan, RA, Riches, ML, Rizzo, JD, Saber, W, Shaw, BE, Spellman, SR, Steinert, P, Weisdorf, DJ & Horowitz, MM 2022, 'Corrigendum to ‘Current Use and Trends in Hematopoietic Cell Transplantation in the United States’ [Transplantation and Cellular Therapy 26/8 (2020) e177-e182, (S1083879120302251), (10.1016/j.bbmt.2020.04.013)]', Transplantation and Cellular Therapy, vol. 28, no. 10, pp. 715-716. https://doi.org/10.1016/j.jtct.2021.02.006

D'Souza A, Fretham C, Lee SJ, Arora M, Brunner J, Chhabra S et al. Corrigendum to ‘Current Use and Trends in Hematopoietic Cell Transplantation in the United States’ [Transplantation and Cellular Therapy 26/8 (2020) e177-e182, (S1083879120302251), (10.1016/j.bbmt.2020.04.013)]. Transplantation and Cellular Therapy. 2022 Oct;28(10):715-716. doi: 10.1016/j.jtct.2021.02.006

@article{ed288669e55e48b7a0eec07018fec3a9,

title = "Corrigendum to {\textquoteleft}Current Use and Trends in Hematopoietic Cell Transplantation in the United States{\textquoteright} [Transplantation and Cellular Therapy 26/8 (2020) e177-e182, (S1083879120302251), (10.1016/j.bbmt.2020.04.013)]",

abstract = "The authors regret an error in the original paper wherein the number of patients with Diffuse Large B Cell Lymphoma (DLBCL) undergoing autologous hematopoietic cell transplantation in the U.S. in 2018 was incorrectly reported. Prior to 2018, the majority of DLBCL were collected under the category {\textquoteleft}NHL diffuse, large B-cell. To align data reporting with 2016 World Health Organization classification of lymphoid neoplasms, in 2018, the CIBMTR forms added new categories (including, DLBCL – germinal center B-cell type, DLBCL – activated B-cell type, and NHL with c-myc and bcl-2 and/or bcl6 rearrangements). We erroneously did not include these newly added subsets of DLBCL, resulting in the appearance of fewer patients undergoing autologous hematopoietic cell transplantation for DLBCL in 2018. Upon identification of this error, we have created an updated Figure 3. The authors would like to apologise for any inconvenience caused.",

author = "Anita D'Souza and Caitrin Fretham and Lee, {Stephanie J.} and Mukta Arora and Janet Brunner and Saurabh Chhabra and Steven Devine and Mary Eapen and Mehdi Hamadani and Parameswaran Hari and Pasquini, {Marcelo C.} and Waleska Perez and Phelan, {Rachel A.} and Riches, {Marcie L.} and Rizzo, {J. Douglas} and Wael Saber and Shaw, {Bronwen E.} and Spellman, {Stephen R.} and Patricia Steinert and Weisdorf, {Daniel J.} and Horowitz, {Mary M.}",

note = "Publisher Copyright: {\textcopyright} 2021 The American Society for Transplantation and Cellular Therapy",

year = "2022",

month = oct,

doi = "10.1016/j.jtct.2021.02.006",

language = "English (US)",

volume = "28",

pages = "715--716",

journal = "Transplantation and Cellular Therapy",

issn = "2666-6367",

publisher = "Elsevier BV",

number = "10",

}

TY - JOUR

T1 - Corrigendum to ‘Current Use and Trends in Hematopoietic Cell Transplantation in the United States’ [Transplantation and Cellular Therapy 26/8 (2020) e177-e182, (S1083879120302251), (10.1016/j.bbmt.2020.04.013)]

AU - D'Souza, Anita

AU - Fretham, Caitrin

AU - Lee, Stephanie J.

AU - Arora, Mukta

AU - Brunner, Janet

AU - Chhabra, Saurabh

AU - Devine, Steven

AU - Eapen, Mary

AU - Hamadani, Mehdi

AU - Hari, Parameswaran

AU - Pasquini, Marcelo C.

AU - Perez, Waleska

AU - Phelan, Rachel A.

AU - Riches, Marcie L.

AU - Rizzo, J. Douglas

AU - Saber, Wael

AU - Shaw, Bronwen E.

AU - Spellman, Stephen R.

AU - Steinert, Patricia

AU - Weisdorf, Daniel J.

AU - Horowitz, Mary M.

PY - 2022/10

Y1 - 2022/10

N2 - The authors regret an error in the original paper wherein the number of patients with Diffuse Large B Cell Lymphoma (DLBCL) undergoing autologous hematopoietic cell transplantation in the U.S. in 2018 was incorrectly reported. Prior to 2018, the majority of DLBCL were collected under the category ‘NHL diffuse, large B-cell. To align data reporting with 2016 World Health Organization classification of lymphoid neoplasms, in 2018, the CIBMTR forms added new categories (including, DLBCL – germinal center B-cell type, DLBCL – activated B-cell type, and NHL with c-myc and bcl-2 and/or bcl6 rearrangements). We erroneously did not include these newly added subsets of DLBCL, resulting in the appearance of fewer patients undergoing autologous hematopoietic cell transplantation for DLBCL in 2018. Upon identification of this error, we have created an updated Figure 3. The authors would like to apologise for any inconvenience caused.

AB - The authors regret an error in the original paper wherein the number of patients with Diffuse Large B Cell Lymphoma (DLBCL) undergoing autologous hematopoietic cell transplantation in the U.S. in 2018 was incorrectly reported. Prior to 2018, the majority of DLBCL were collected under the category ‘NHL diffuse, large B-cell. To align data reporting with 2016 World Health Organization classification of lymphoid neoplasms, in 2018, the CIBMTR forms added new categories (including, DLBCL – germinal center B-cell type, DLBCL – activated B-cell type, and NHL with c-myc and bcl-2 and/or bcl6 rearrangements). We erroneously did not include these newly added subsets of DLBCL, resulting in the appearance of fewer patients undergoing autologous hematopoietic cell transplantation for DLBCL in 2018. Upon identification of this error, we have created an updated Figure 3. The authors would like to apologise for any inconvenience caused.

UR - http://www.scopus.com/inward/record.url?scp=85108559179&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85108559179&partnerID=8YFLogxK

U2 - 10.1016/j.jtct.2021.02.006

DO - 10.1016/j.jtct.2021.02.006

M3 - Comment/debate

C2 - 36202526

AN - SCOPUS:85108559179

SN - 2666-6367

VL - 28

SP - 715

EP - 716

JO - Transplantation and Cellular Therapy

JF - Transplantation and Cellular Therapy

IS - 10

ER -

Corrigendum to ‘Current Use and Trends in Hematopoietic Cell Transplantation in the United States’ [Transplantation and Cellular Therapy 26/8 (2020) e177-e182, (S1083879120302251), (10.1016/j.bbmt.2020.04.013)]

Abstract

Bibliographical note

PubMed: MeSH publication types

UN SDGs

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this